NCT05742750 2023-02-24A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract CancerSun Yat-sen UniversityPhase 1/2 Unknown48 enrolled
NCT03311789 2017-10-17Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCsChinese PLA General HospitalPhase 1/2 Unknown30 enrolled